Name: Drontal Tablets (cats)
Category: Antihelmintics
Active ingredients: Praziquantel 20 mg and pyrantel embonate 230 mg
Excipients: Corn starch, microcrystalline cellulose, polyvidone, magnesium stearate, colloidal anhydrous silica, hydroxypropyl methylcellulose, pPolyethylene glycol 4000, titanium dioxide
Pharmaceutical form: Blister
Container: Tablets
Target species: Cats
Indications: Treatment of mixed infestations of cats by roundworms and tapeworms, caused by: Roundworms (Toxocara cati sin. mystax, Toxascaris leonina); Hookworms (Ancylostoma tubaeforme, Ancylostoma braziliense); Tapeworms (Echinococcus granulosus, Echinococcus multilocularis, Dipylidium caninum, Taenia spp., Mesocestoides spp., Joyeuxiella spp.).
Contraindications: Do not use in animals with known hypersensitivity to the active ingredients or to any of the excipients. It should not be used during pregnancy. Do not use in kittens under 4 weeks of age. Do not use simultaneously with piperazine-based compounds.
Side effects: None known.
Use during pregnancy, breastfeeding or lay: Should not be used during pregnancy.
Interaction with other veterinary medicinal products and other forms of interaction: None known.
Dosage and route of administration: The dose is 5 mg of praziquantel and 57.5 mg of pyrantelembonate per kg of body weight. This corresponds to 1 tablet for every 4 kg of body weight. The tablet can be divided as needed. The tablets are administered directly or by wrapping them in a piece of meat or sausage or with the feed by chopping them up. No dietary measures are necessary. The use occurs in a single solution.
Overdose (symptoms, emergency procedures, antidotes) if necessary: In order to achieve effective parasite control the treatment should be carried out according to the results of the parasitological examination.To ensure correct dosing, animals should be weighed. Since tapeworm infestation in cats does not appear before the 3rd (a) week of life, treatment with the drug is indicated only after the 3rd (a) week of life. Resistance of parasites to a particular class of anthelmintics may develop following frequent, repeated use of an anthelmintic of the same class. Echinococcosis represents a danger to humans. In case of echinococcosis, specific guidelines must be followed for treatment and follow-up and for the protection of people. Do not use in severely debilitated animals or with severely impaired hepatic or renal function. Special precautions to be taken by the person administering the product to animals: People with known hypersensitivity to the active ingredients contained in this medicinal product should administer the product with caution. Wash your hands after use. Avoid contact with eyes. In case of eye irritation, contact a doctor. Do not eat, drink or smoke while using the product. Overdose: Symptoms of overdose are not evident with doses up to 5 times the recommended dose. The first expected symptom of intoxication is vomiting.
Waiting time: Not applicable.
Storage: This medicinal product does not require any special storage conditions.